Vectors - Shuttle vehicles for gene therapy

Clinical and Experimental Immunology, Supplement

Volumn 107, Issue SUPPL. 1, 1997, Pages 31-32

  Wilson, J M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

Cystic fibrosis; Gene therapy; Host responses; Vectors

Indexed keywords

DNA;

ADENOVIRUS; CONFERENCE PAPER; CYSTIC FIBROSIS; GENE EXPRESSION; GENE TECHNOLOGY; GENE THERAPY; GENE TRANSFER; HUMAN; PRIORITY JOURNAL;

CYSTIC FIBROSIS; GENE THERAPY; GENETIC DISEASES, INBORN; GENETIC VECTORS; HUMANS;

EID: 0031022572     PISSN: 09642536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Mulligan RC. The basic science of gene therapy. Science 1993; 260:926-32.
2. - immunodeficient patients. Science 1995; 270:470-4.
3. Crystal RG, McElvaney NG, Rosenfeld, MA et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet 1994; 8:42-51.
4. Wilson JM. Gene therapy for cystic fibrosis: challenges and future directions. J Clin Invest 1995; 96:2547-54.